Stroke Trial, Recruiting NCT07363525 Sponsor: Henry Ford Health System Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07363525
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to hospital with a blocked major blood vessel in the brain and treated with a device called the Tigertriever, according to its approved use.
  • People for whom the Tigertriever was used as the first treatment attempt in the affected blood vessel.
  • People who have given written agreement to take part in the trial.
  • People aged 18 or older.

Who may not be able to join:

  • People who show signs of acute bleeding in the brain on a scan taken at the time of admission.
  • People who have had a brain bleed, stroke, clot-dissolving treatment, or a procedure to treat a blocked blood vessel in the past 3 months.
  • People who already had some level of disability before their stroke (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 313-916-2644

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Henry Ford Health System
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Modified Rankin Scale; Primary Effectiveness Endpoint; Primary Effectiveness Endpoint - mTICI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov